CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at Cowen and Company's 37th Annual Health Care Conference to
be held at the Marriott Copley Place in Boston, Massachusetts on
Wednesday, March 8, 2017. The presentation will be delivered by Hany
Massarany, President and Chief Executive Officer, and is scheduled
to begin at 10:00 a.m. Eastern Time. The presentation will be made
available at http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
Diagnostics (NASDAQ: GNMK) is a leading provider of automated,
multiplex molecular diagnostic testing systems that detect and measure
DNA and RNA targets to diagnose disease and optimize patient treatment.
Utilizing GenMark's proprietary eSensor® detection technology, GenMark's
eSensor XT-8® system is designed to support a broad range of molecular
diagnostic tests with a compact, easy-to-use workstation and
self-contained, disposable test cartridges. The eSensor detection
technology is also incorporated into GenMark's new sample-to-answer
system ePlex®. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170302006257/en/
GenMark Diagnostics, Inc.
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media